IRIS PubliCatt

Tolusso, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.259
EU - Europa 3.207
AS - Asia 800
AF - Africa 28
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 4
Totale 7.319
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.241
DE - Germania 725
IT - Italia 550
SE - Svezia 534
PL - Polonia 486
CN - Cina 436
FR - Francia 276
IE - Irlanda 176
SG - Singapore 167
UA - Ucraina 158
GB - Regno Unito 92
IN - India 88
FI - Finlandia 56
RU - Federazione Russa 48
BE - Belgio 37
TR - Turchia 33
CI - Costa d'Avorio 22
JP - Giappone 19
HK - Hong Kong 18
CA - Canada 13
CZ - Repubblica Ceca 12
NL - Olanda 12
CH - Svizzera 11
IR - Iran 11
VN - Vietnam 8
RO - Romania 7
EU - Europa 6
AR - Argentina 4
GR - Grecia 4
IL - Israele 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AU - Australia 3
BD - Bangladesh 3
BG - Bulgaria 3
CL - Cile 3
KR - Corea 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
MX - Messico 3
NG - Nigeria 3
ZA - Sudafrica 3
AT - Austria 2
CO - Colombia 2
DK - Danimarca 2
EE - Estonia 2
ES - Italia 2
HU - Ungheria 2
ID - Indonesia 2
LU - Lussemburgo 2
NO - Norvegia 2
SA - Arabia Saudita 2
A1 - Anonimo 1
AL - Albania 1
BO - Bolivia 1
BZ - Belize 1
CR - Costa Rica 1
EC - Ecuador 1
GE - Georgia 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
Totale 7.319
Salva come PNG Salva come JPEG
Città #
Chandler 640
Warsaw 457
Ashburn 246
Fairfield 191
Ann Arbor 165
Dublin 162
Dearborn 150
Wilmington 126
Woodbridge 120
New York 117
Rome 103
Jacksonville 101
Seattle 101
Nanjing 100
San Mateo 94
Singapore 91
Cattolica 78
Houston 78
Milan 73
Beijing 62
Cambridge 62
Boston 56
Bremen 51
Princeton 51
Marseille 43
Chicago 37
Moscow 36
Nürnberg 32
Brussels 31
Lawrence 31
Redwood City 30
Izmir 29
Pune 26
Munich 25
Norwalk 23
Abidjan 22
Boardman 22
Kraków 22
Los Angeles 22
Redmond 21
Nanchang 20
Kunming 19
Helsinki 18
Hong Kong 18
Lancaster 18
Hebei 16
Hangzhou 15
Mountain View 15
Leawood 14
Shenyang 14
Tianjin 14
Busto Arsizio 13
Hefei 13
London 13
Falls Church 12
Jiaxing 12
Santa Maria 12
Andover 10
Augusta 10
Brno 10
Tokyo 10
Guangzhou 9
Phoenix 9
Changsha 8
Dong Ket 8
Fremont 8
Jinan 8
San Diego 8
Simi Valley 8
University Park 8
Fuzhou 7
Ningbo 7
Parma 7
Toronto 7
Zhengzhou 7
Zurich 7
Amsterdam 6
Cagliari 6
Detroit 6
Herenthout 6
Washington 6
Boydton 5
Chengdu 5
Forest City 5
Mumbai 5
Rozzano 5
Shanghai 5
Wuhan 5
Ardabil 4
Edinburgh 4
Enterprise 4
Ghaziabad 4
Naples 4
Paris 4
Renton 4
Ashfield 3
Bari 3
Bern 3
Catania 3
Changchun 3
Totale 4.447
Salva come PNG Salva come JPEG
Nome #
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue 375
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis 298
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis 267
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 256
B CELL DEPLETION IN DIFFUSE PROGRESSIVE SYSTEMIC SCLEROSIS: SAFETY, SKIN SCORE MODIFICATION AND IL-6 MODULATION IN AN UP TO THIRTY-SIX MONTHS FOLLOW-UP OPEN-LABEL TRIAL 234
MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis. 206
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 186
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. 163
B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status 134
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue. 134
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis 134
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis 132
A vascular endothelial growth factor deficiency characterises scleroderma lung disease 128
Very early rheumatoid arthritis is the major predictor of major outcome: clinical ACR remission and radiographic non-progression. 125
ZAP-70+ B Cell Subset Influences Response to B Cell Depletion Therapy and Early Repopulation in Rheumatoid Arthritis 121
The role of High-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on Vascular endothelial growth factor. 121
B CELLS IN SYSTEMIC SCLEROSIS: A POSSIBLE TARGET FOR THERAPY 118
Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis 115
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 107
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 106
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission 97
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. 96
Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: A clue to interpret different chances of relapse after clinical remission? 88
Chemerin and PEDF are metaflammation-related biomarkers of disease activity and obesity in rheumatoid arthritis 88
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 83
Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis 82
Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations 82
Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis 82
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 80
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 80
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 79
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 77
Is Citrullination Required for the Presence of Restricted Clonotypes Reacting With Type II Collagen? Comment on the Article by Chemin et al 77
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 76
Synovial tissue derived characteristics are included in a nomogram for the prediction of treatment response in naïve Rheumatoid Arthritis 75
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 74
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 73
Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases) 70
Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus 69
Sarilumab use in severe SARS-CoV-2 pneumonia 69
Therapeutic drug monitoring is more cost-effective than a clinically-based approach in the management of loss of response to infliximab in inflammatory bowel disease: an observational multi-centre study. 68
Thymosin β4 and β10 in Sjögren's syndrome: Saliva proteomics and minor salivary glands expression 67
Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients 65
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 65
Comparative analysis of synovial inflammation after SARS-CoV-2 infection 64
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 63
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study 62
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 61
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 60
Is it necessary to be citrullinated to have restricted clonotypes reacting with Collagen type II? Comment to article "A novel HLA-DRB1*10:01 restricted T cell epitope from citrullinated type II collagen relevant for Rheumatoid Arthritis" 59
Comment on: Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease 59
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 59
Correction to: Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: influence of the disease severity and therapy on the ovarian reserve (Endocrine, (2019), 63, 2, (369-375), 10.1007/s12020-018-1783-1) 57
Do we need to apply a T2T strategy even in ACPA-negative early rheumatoid arthritis? YES 56
Weight Loss, The Obesity Paradox in Rheumatoid Arthritis: Is It a Paradox? Comment on the Article by Baker et al 56
Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: Influence of the disease severity and therapy on the ovarian reserve 54
Paradoxical arthritis occurring during anti-TNF in patients with Inflammatory Bowel Disease: histological and immunological features of a complex synovitis. 52
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 52
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 51
The B side of rheumatoid arthritis pathogenesis 51
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 51
Prevalence and Determinants of Peripheral Microvascular Endothelial Dysfunction in Rheumatoid Arthritis Patients: A Multicenter Cross-Sectional Study. 50
Synovial predictors of differentiation to definite arthritis in patients with seronegative undifferentiated peripheral inflammatory arthritis: MicroRNA signature, histological, and ultrasound features 50
Should rheumatoid factor (RF) (and antinuclear antibodies (ANA)) become routinary screening test for morbidities in the general population?: From the concept of “benign autoimmunity “to the concept of” autoimmunity as a red flag in preventive medicine”? 49
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 49
Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: A case report 48
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 45
Prevalence and Determinants of Peripheral Microvascular Endothelial Dysfunction in Rheumatoid Arthritis Patients: A Multicenter Cross-Sectional Study 43
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered 43
Basic immunology may lead to translational therapeutic rationale: SARS-CoV-2 and rheumatic diseases 41
Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of Immunogenicity 39
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 38
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 38
Effects of l-Arginine Plus Vitamin C Supplementation on l-Arginine Metabolism in Adults with Long COVID: Secondary Analysis of a Randomized Clinical Trial 36
Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: An old tool for new biomarkers 36
Depression and Endothelial Dysfunction in Psoriatic Arthritis: Is There Any Possible Relationship? 36
JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy 35
Basophil activation and serum IL-5 levels as possible monitor biomarkers in severe eosinophilic asthma patients treated with anti-IL-5 drugs 34
Pro Nerve Growth Factor and Its Receptor p75NTR Activate Inflammatory Responses in Synovial Fibroblasts: A Novel Targetable Mechanism in Arthritis 32
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 30
Psoriatic arthritis and depressive symptoms: does systemic inflammation play a role? 29
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis 28
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA 28
Loss of α2-6 sialylation promotes the transformation of synovial fibroblasts into a pro-inflammatory phenotype in arthritis 27
Is ACPA positivity the main driver for rheumatoid arthritis treatment? Pros and cons 26
Effects of l-Arginine Plus Vitamin C Supplementation on Physical Performance, Endothelial Function, and Persistent Fatigue in Adults with Long COVID: A Single-Blind Randomized Controlled Trial 25
The Role of High-Mobility Group Box-1 and Its Crosstalk with Microbiome in Rheumatoid Arthritis 24
Peripheral blood CD4posCD25posFoxP3pos cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig 23
Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19 22
Could we use a lower dose of rituximab to treat rheumatoid arthritis in clinical practice: Pros and cons? 20
Intensive training programme for ultrasound-guided minimally invasive synovial tissue biopsy on knees and wrists in different phases of inflammation 18
COVID-19 atypical Parsonage-Turner syndrome: a case report 17
Malnutrition in COVID-19 survivors: prevalence and risk factors 17
Driving chronicity in rheumatoid arthritis: Perpetuating role of myeloid cells 17
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 11
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 11
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 11
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 11
Diagnostic performance of anti-citrullinated peptide antibodies for the diagnosis of rheumatoid arthritis: the relevance of likelihood ratios 10
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 9
Totale 7.445
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.289
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.289
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.102 0 0 112 191 113 172 115 73 80 82 114 50
2020/2021732 68 60 47 50 89 37 78 12 92 70 100 29
2021/2022915 119 62 38 61 65 29 28 103 41 67 133 169
2022/20231.893 220 239 150 300 117 224 92 140 235 62 63 51
2023/20241.112 42 253 46 64 45 189 81 52 14 78 160 88
2024/202595 48 47 0 0 0 0 0 0 0 0 0 0
Totale 7.480